Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 628.32 Million

CAGR (2025-2030)

8.45%

Fastest Growing Segment

Infectious Disease

Largest Market

     South India

Market Size (2030)

USD 1,024.57 Million

Market Overview

India Point of Care Diagnostics Market was valued at USD 628.32 Million in 2024 and is expected to reach USD 1,024.57 Million by 2030 with a CAGR of 8.45% during the forecast period. The India Point of Care (POC) Diagnostics Market is experiencing significant growth, driven by a combination of rising healthcare demands and technological advancements. The increasing prevalence of chronic diseases such as diabetes and cardiovascular conditions, along with the growing burden of infectious diseases, is fueling the demand for quick and efficient diagnostic solutions. Additionally, the expanding healthcare infrastructure in rural areas, supported by government initiatives like Ayushman Bharat, is improving access to POC diagnostics. Technological innovations, such as mobile health integration and portable diagnostic devices, are enhancing the accuracy and convenience of these tests, making them more accessible to both urban and rural populations.

However, challenges such as the high cost of advanced POC devices, regulatory hurdles, and limited reimbursement policies in certain regions of India still pose barriers to market growth. Moreover, the lack of widespread awareness about POC testing in rural areas and concerns over the quality of some low-cost devices further complicate market expansion. Despite these challenges, the sector's potential is bolstered by the increasing health-consciousness of the Indian population, driving both demand and adoption of POC diagnostic technologies.

Key Market Drivers

Rising Prevalence of Chronic Diseases

India is witnessing a significant rise in the prevalence of chronic diseases, a trend that is driving the growth of the Point of Care (POC) diagnostics market. As healthcare challenges continue to evolve, the burden of chronic conditions is placing increasing strain on the country's healthcare system. Chronic diseases, such as hypertension, diabetes, and cardiovascular diseases, are now becoming prevalent across various demographic segments, particularly in urban areas where lifestyle-related factors like poor diet, lack of physical activity, and stress are more common. This rapid rise in chronic diseases emphasizes the need for more accessible, efficient, and timely diagnostic solutions to manage these conditions effectively.

Recent studies show that nearly 41.73% of adults in India suffer from at least one chronic condition. Among these, hypertension affects 26.82% of the population, while diabetes impacts 12.24%. The growing incidence of lifestyle-related diseases, particularly in urban areas, has contributed significantly to this rise. A report from the Indian Council of Medical Research (ICMR) highlights that the number of diabetic patients in India is expected to surpass 134 million by 2045, positioning the country to become home to the second-largest diabetic population in the world. Furthermore, the Indian Heart Association estimates that cardiovascular diseases will account for 60% of all deaths in India by 2025, further stressing the need for early diagnosis and effective management of these diseases.

Given these alarming statistics, the demand for Point of Care diagnostics has grown exponentially. POC diagnostics offer the promise of early detection and continuous monitoring of chronic conditions, enabling patients to manage their health more effectively and healthcare providers to intervene in a timely manner. These diagnostics play a critical role in reducing the burden on healthcare systems, particularly in resource-limited areas. As the prevalence of chronic diseases continues to rise, the demand for POC diagnostics is expected to grow, driven by the need for quicker, cost-effective, and accessible solutions to manage and monitor these conditions.

Growing Aging Population

The growing aging population in India is another significant driver for the Point of Care (POC) diagnostics market. As life expectancy increases and the proportion of elderly people in the population rises, there is an increasing demand for healthcare solutions that can cater to the unique needs of older adults. The elderly population is more prone to chronic diseases, cognitive impairments, and age-related conditions, which necessitate frequent medical check-ups and continuous monitoring. This demographic shift is contributing to a greater need for diagnostic tools that can provide quick, accurate, and convenient results at the point of care, especially in home healthcare settings, long-term care facilities, and outpatient clinics.

India’s aging population is growing rapidly, with the number of people aged 60 and above expected to nearly triple by 2050. According to the United Nations Population Fund (UNFPA), in 2021, approximately 10.1% of India’s population was aged 60 or older, and this proportion is projected to reach 19.5% by 2050. The elderly population is more susceptible to chronic conditions like hypertension, diabetes, heart disease, and cancer, which require ongoing monitoring and management.

Additionally, data from the National Sample Survey Organization (NSSO) indicates that more than 70% of elderly people in India suffer from at least one chronic disease, underscoring the growing healthcare needs of this group. With the healthcare system facing the challenge of providing care for an aging population, Point of Care diagnostics can address these needs by providing cost-effective, reliable, and rapid testing for a wide range of conditions. POC technologies, such as blood glucose meters, blood pressure monitors, and cholesterol testing devices, can enable better disease management at home or in rural areas, reducing hospital visits and enhancing the quality of care for elderly patients.

In conclusion, the rapidly increasing aging population in India presents a strong demand for POC diagnostics, as older adults require continuous monitoring and management of chronic diseases. With the elderly population expected to grow significantly over the next few decades, the POC diagnostics market is set to experience substantial growth, offering solutions to meet the healthcare needs of India’s aging demographic.

India Point of Care Diagnostics Market

Download Free Sample Report

Key Market Challenges

Limited Awareness and Education

Limited awareness and education about Point of Care (POC) diagnostics remain significant challenges to the widespread adoption of these technologies in India. While urban areas have seen growing awareness of the benefits and convenience offered by POC diagnostics, rural and remote regions lag behind in understanding how these devices can improve healthcare outcomes. Many healthcare professionals in smaller clinics, particularly in underserved areas, may not be familiar with the latest advancements in POC technologies or may lack proper training on how to effectively use these devices. This gap in knowledge creates a barrier to integrating POC diagnostics into daily healthcare practices.

Additionally, patients themselves may not fully understand the importance of rapid, in-situ testing for early disease detection and management, leading to hesitancy in utilizing POC services. This lack of awareness often results in underutilization of POC diagnostics, especially in rural regions where access to advanced healthcare facilities is limited. Increasing education and awareness about the potential benefits and proper usage of POC devices, both for healthcare professionals and patients, is essential to boost adoption and ensure that these technologies are fully leveraged to improve healthcare accessibility and outcomes across India.

Key Market Trends

Technological Advancement

Technological advancement is a major trend that is reshaping the Point of Care (POC) diagnostics market in India. With rapid progress in medical technology, POC diagnostic devices have evolved from basic tools to highly sophisticated, portable, and efficient instruments that can deliver fast, accurate results. These advancements have played a crucial role in driving the adoption of POC diagnostics across healthcare settings, from hospitals to remote clinics and even home care.

One of the key advancements is the integration of digital and mobile technologies, enabling POC devices to be connected to smartphones, tablets, and cloud-based platforms. This allows for real-time data transmission, remote monitoring, and storage, making it easier for healthcare providers to track patient conditions and share information instantly. For instance, devices that measure glucose levels, blood pressure, or cholesterol can now transmit results directly to a central database, where medical professionals can access and analyze them, regardless of location. This connectivity not only enhances the speed and accuracy of diagnosis but also facilitates continuous patient monitoring, which is particularly important for chronic disease management.

Another notable advancement is the miniaturization of diagnostic devices. Today’s POC diagnostic tools are smaller, more user-friendly, and require less training to operate. This has significantly increased their accessibility in both rural and urban settings, where healthcare infrastructure may be lacking. Devices like handheld glucose meters, portable ECG machines, and compact pregnancy test kits are enabling patients to perform tests at home or in outpatient clinics without the need for extensive laboratory equipment.

Moreover, innovations in biosensors and biomarker technologies have significantly improved the sensitivity and specificity of POC devices. These advances allow for earlier detection of diseases, including infectious diseases, diabetes, cardiovascular conditions, and cancer markers, with minimal sample volumes. Additionally, technologies like microfluidics and nanotechnology are enhancing the capabilities of POC devices, allowing them to perform multiple tests with higher precision and speed on a single device.

Segmental Insights

Product Insights

Based on Product, Infectious Disease emerged as the fastest growing segment in the India Point of Care Diagnostics Market in 2024. This is due to a combination of factors, particularly the rising incidence of infectious diseases and the increasing demand for rapid, on-site diagnostic solutions. Infectious diseases such as tuberculosis, malaria, hepatitis, dengue, and COVID-19 remain prevalent across India, with significant outbreaks occurring periodically. The urgency of diagnosing these diseases quickly to ensure timely treatment and prevent further transmission has highlighted the need for POC diagnostic tools. These devices allow healthcare providers to quickly detect infections in a variety of settings, including rural and remote areas where traditional laboratory services may not be readily available.

The COVID-19 pandemic further accelerated the growth of the Infectious Disease segment, as POC testing became a critical tool for mass testing, monitoring, and controlling the spread of the virus. As a result, there has been an increased focus on the development and adoption of portable, user-friendly diagnostic devices capable of providing results in a matter of minutes. Beyond COVID-19, the ongoing concerns over diseases like tuberculosis, HIV, and vector-borne diseases such as dengue and malaria are driving demand for faster and more efficient diagnostic solutions.

End Use Insights

Based on End Use, Home emerged as the fastest growing segment in the India Point of Care Diagnostics Market during the forecast period. due to a combination of factors that reflect the changing healthcare dynamics in the country. The increasing preference for at-home healthcare solutions, driven by convenience, cost-effectiveness, and the desire for timely results, has significantly contributed to the rise of home care diagnostics. With more people seeking to monitor their health independently, especially for chronic conditions such as diabetes, hypertension, and heart disease, home diagnostic tools have become an essential part of personal healthcare management.

Advancements in technology, particularly the development of user-friendly devices like blood glucose meters, home pregnancy tests, cholesterol monitors, and pulse oximeters, have made it easier for individuals to perform tests without requiring professional assistance. These devices are designed to be simple, accurate, and accessible, empowering patients to take control of their health. For instance, continuous glucose monitoring systems, which were once primarily used in hospitals, are now available for home use, allowing diabetic patients to track their blood sugar levels regularly.

India Point of Care Diagnostics Market

Download Free Sample Report

Regional Insights

Based on Region, South India have emerged as the dominating region in the India Point of Care Diagnostics Market in 2024. due to a combination of factors that reflect the changing healthcare dynamics in the country. South India is dominating the Point of Care (POC) diagnostics market due to a combination of factors, including its advanced healthcare infrastructure, high urbanization, and significant investments in healthcare technology. The region is home to some of the country’s leading cities, such as Bengaluru, Chennai, Hyderabad, and Kochi, which are known for their thriving healthcare sectors. These cities have well-established healthcare facilities, including hospitals, clinics, and diagnostic centers, that increasingly adopt POC diagnostic solutions due to their efficiency and convenience. Additionally, South India has a large concentration of healthcare professionals and institutions focusing on research and development in medical technologies, which supports the widespread adoption of innovative POC devices.

Another driving factor is the region's growing middle class, which has led to increased healthcare spending and a higher demand for quality diagnostic services. South India's strong education system, along with its large pool of skilled professionals in medical technology, further promotes the adoption of POC diagnostics. The region's focus on preventive healthcare, coupled with increasing awareness of chronic diseases like diabetes, cardiovascular issues, and infectious diseases, has created a fertile ground for the growth of the POC diagnostics market.

Recent Development

  • In June 2024, India’s innovative tuberculosis (TB) diagnostic technology received acclaim at the 2024 World Health Assembly for its rapid, accurate point-of-care testing. The technology allows faster TB detection, crucial for global health efforts. Recognized for its potential in resource-limited areas, it supports India’s goal to eliminate TB by 2030.
  • In May 2024, Cipla has increased its investment in point-of-care testing company Achira Labs to enhance the development of advanced diagnostic solutions. The partnership aims to accelerate the availability of innovative, rapid diagnostic tests, strengthening Cipla's presence in the healthcare technology sector and expanding access to affordable healthcare solutions.
  • In April 2024, Roche Diagnostics India’s launch of a heart failure test specifically for diabetics as a point-of-care (POC) device marks a significant step in advancing personalized healthcare. This test is designed to provide rapid, on-site diagnostics for heart failure in diabetic patients, a group that is at a higher risk of cardiovascular diseases due to the long-term effects of diabetes on the heart and blood vessels.
  • In October 2023, Serum Institute of India and Mylab have launched a new tuberculosis (TB) diagnostic kit for detecting latent TB infections. This innovative kit provides a quicker, more accessible method for identifying latent TB, which can help in early intervention and prevent the progression to active TB, enhancing public health efforts.

Key Market Players

  • Roche Products (India) Pvt. Ltd.
  • Qiagen India Pvt Ltd.
  • Danaher Corporation
  • Becton Dickinson Private Limited
  • BioMérieux
  • Siemens Healthcare Private Limited
  • Abbott India Ltd
  • Trividia Health, Inc.
  • Spectra Medical India Pvt Ltd
  • AccuBioTech Co., Ltd.

By Product

By End Use

By Region

  • Glucose Testing
  • Hb1Ac Testing
  • Coagulation Testing
  • Fertility/Pregnancy
  • Infectious Disease
  • Cardiac Markers
  • Thyroid Stimulating Hormone
  • Hematology
  • Primary Care Systems
  • Others
  • Clinics
  • Hospitals
  • Home
  • Assisted Living Healthcare Facilities
  • Laboratory
  • East India
  • West India
  • North India
  • South India

Report Scope

In this report, the India Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • India Point of Care Diagnostics Market, By Product:

o   Glucose Testing

o   Hb1Ac Testing

o   Coagulation Testing

o   Fertility/Pregnancy

o   Infectious Disease

o   Cardiac Markers

o   Thyroid Stimulating Hormone

o   Hematology

o   Primary Care Systems

o   Others

  • India Point of Care Diagnostics Market, By End Use:

o   Clinics

o   Hospitals

o   Home

o   Assisted Living Healthcare Facilities

o   Laboratory

  • India Point of Care Diagnostics Market, By Region:

o   East India

o   West India

o   North India

o   South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Point of Care Diagnostics Market.

Available Customizations:

India Point of Care Diagnostics Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

India Point of Care Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

Table of content

1.       Product Overview

1.1.    Market Definition

1.2.    Scope of the Market

1.2.1.Markets Covered

1.2.2.Years Considered for Study

1.2.3.Key Market Segmentations

2.       Research Methodology

2.1.    Objective of the Study

2.2.    Baseline Methodology

2.3.    Key Industry Partners

2.4.    Major Association and Secondary Sources

2.5.    Forecasting Methodology

2.6.    Data Triangulation & Validation

2.7.    Assumptions and Limitations

3.       Executive Summary

3.1.    Overview of the Market

3.2.    Overview of Key Market Segmentations

3.3.    Overview of Key Market Players

3.4.    Overview of Key Regions/Countries

3.5.    Overview of Market Drivers, Challenges, Trends

4.       India Point of Care Diagnostics Market Outlook

4.1.    Market Size & Forecast

4.1.1.By Value

4.2.    Market Share & Forecast

4.2.1.By Product (Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Others)

4.2.2.By End Use (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory)

4.2.3.By Region

4.2.4.By Company (2025)

4.3.    Market Map

4.3.1.By Product

4.3.2.By End Use

4.3.3.By Region

5.       East India Point of Care Diagnostics Market Outlook

5.1.    Market Size & Forecast     

5.1.1.By Value

5.2.    Market Share & Forecast

5.2.1.By Product

5.2.2.By End Use

6.       West India Point of Care Diagnostics Market Outlook

6.1.    Market Size & Forecast     

6.1.1.By Value

6.2.    Market Share & Forecast

6.2.1.By Product

6.2.2.By End Use

7.       North India Point of Care Diagnostics Market Outlook

7.1.    Market Size & Forecast     

7.1.1.By Value

7.2.    Market Share & Forecast

7.2.1.By Product

7.2.2.By End Use

8.       South India Point of Care Diagnostics Market Outlook

8.1.    Market Size & Forecast     

8.1.1.By Value

8.2.    Market Share & Forecast

8.2.1.By Product

8.2.2.By End Use

9.       Market Dynamics

9.1.    Drivers

9.2.    Challenges

10.   Market Trends & Developments

10.1.      Recent Developments

10.2.      Product Launches

10.3.      Mergers & Acquisitions

11.   Policy & Regulatory Landscape

12.   India Economic Profile

13.   Competitive Landscape

13.1.      Roche Products (India) Pvt. Ltd.

13.1.1.    Business Overview

13.1.2.    Company Snapshot

13.1.3.    Products & Services

13.1.4.    Financials (In case of listed)

13.1.5.    Recent Developments

13.1.6.    SWOT Analysis

13.2.      Qiagen India Pvt Ltd.

13.3.      Danaher Corporation

13.4.      Becton Dickinson Private Limited

13.5.      BioMérieux

13.6.      Siemens Healthcare Private Limited

13.7.      Abbott India Ltd

13.8.      Trividia Health, Inc.

13.9.      Spectra Medical India Pvt Ltd

13.10.   AccuBioTech Co., Ltd.

14.   Strategic Recommendations

15.   About us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the India Point of Care Diagnostics Market was estimated to be USD 628.32 Million in 2024.

The infectious diseases segment demonstrated significant growth in 2024. This is due to increased demand for rapid, accurate diagnostics driven by disease outbreaks, technological advancements, and the need for accessible healthcare solutions in India.

South India dominated the market with a revenue share in 2024. This is due to advanced healthcare infrastructure, high urbanization, significant healthcare investments, strong research and development presence, increasing awareness of chronic diseases, and growing demand for innovative diagnostic solutions across the region.

Rising prevalence of chronic diseases and growing aging population are the major drivers for the India Point of Care Diagnostics Market.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.